{
    "clinical_study": {
        "@rank": "35129", 
        "arm_group": {
            "arm_group_label": "[18F]NAV4694", 
            "arm_group_type": "Experimental", 
            "description": "Intravenous [18F]NAV4694 radioactive dose 8.1 mCi(300 MBq) given once"
        }, 
        "brief_summary": {
            "textblock": "To Determine the the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral\n      \u03b2-Amyloid When Compared With Postmortem Histopathology"
        }, 
        "brief_title": "A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Dementia", 
            "Alzheimer's Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Alzheimer Disease", 
                "Dementia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female subjects will be at least 21 years of age.\n\n          -  Subjects will have a life expectancy of approximately 6 months.\n\n          -  Female subjects will not be of child-bearing potential or will have a negative urine\n             pregnancy test on day of [18F]NAV4694 injection.\n\n          -  Must be able to provide informed consent or assent, and exhibit adequate visual,\n             auditory, and communication capabilities to enable compliance with study procedures.\n             This includes being able to lie down flat in the MRI and PET scanner for a period of\n             approximately 1 hour.\n\n          -  Subjects must be willing to donate their brains for post mortem examination upon\n             death (this consent can be obtained in the manner specific to the country/region\n             involved).\n\n          -  Subjects have been fully informed about the study, including provisions of the Health\n             Insurance Portability and Accountability Act (HIPAA), as applicable, and informed\n             consent or assent has been signed and dated (with time) by the subject and/or the\n             subject's legally acceptable representative (LAR) (for individuals with dementia).\n\n          -  Subjects who have participated in a previous [18F]NAV4694 study may be included in\n             the present study.  The MRI and/or [18F]NAV4694 scan do not need to be repeated if\n             they were performed within 12 months prior to inclusion.\n\n        Exclusion Criteria:\n\n          -  Scheduled for surgery and/or another invasive procedure within the time period of up\n             to 7 days after [18F]NAV4694 injection.\n\n          -  Has severe cerebral macrovascular (i.e., multi-stroke) disease or brain tumor\n             (metastasis/brain cancer) as verified by MRI that prohibits sampling of the required\n             pre-specified ROIs.\n\n          -  Has received any contrast material (X-ray, MRI) or radiopharmaceutical within 48\n             hours prior to, or a therapeutic radiopharmaceutical (e.g., 131I) within 10 days\n             prior to, or any radiopharmaceutical administration within 10 radioactive half-lives\n             prior to the administration of the investigational product or for whom administration\n             of such substances is planned within 7 days after investigational product\n             administration.\n\n          -  Has any contraindication to MRI examination, e.g., metal implants or phobia as\n             determined by the on-site radiologist performing the scan.\n\n          -  Is allergic to the investigational product or any of its constituents."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "290", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01886820", 
            "org_study_id": "NAV4-02"
        }, 
        "intervention": {
            "arm_group_label": "[18F]NAV4694", 
            "intervention_name": "[18F]NAV4694", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Dementia", 
            "Alzheimer's Disease", 
            "Terminally Ill"
        ], 
        "lastchanged_date": "May 5, 2014", 
        "location": [
            {
                "contact": {
                    "email": "Carolyn.Liebsack@bannerhealth.com", 
                    "last_name": "Carolyn Liebsack", 
                    "phone": "623-832-6514"
                }, 
                "contact_backup": {
                    "email": "Michele.Caverly@bannerhealth.com", 
                    "last_name": "Michele Caverly", 
                    "phone": "(623) 832-6529"
                }, 
                "facility": {
                    "address": {
                        "city": "Sun City", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85351"
                    }, 
                    "name": "Banner Sun Health Research Institute"
                }, 
                "investigator": {
                    "last_name": "Marwan Sabbagh, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "hvanderswag@ucsd.edu", 
                    "last_name": "Helen Vanderswag", 
                    "phone": "858-246-1245"
                }, 
                "facility": {
                    "address": {
                        "city": "La Jolla", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92093"
                    }, 
                    "name": "University of California San Diego"
                }, 
                "investigator": {
                    "last_name": "James Brewer, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32224"
                    }, 
                    "name": "Mayo Clinic Jacksonville"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "Isael.Santos@msmc.com", 
                    "last_name": "Isael Santos", 
                    "phone": "305-674-2018"
                }, 
                "facility": {
                    "address": {
                        "city": "Miami Beach", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33140"
                    }, 
                    "name": "Mount Sinai Medical Center of Florida"
                }, 
                "investigator": {
                    "last_name": "Ranjan Duara, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "luisp@galizresearch.com", 
                    "last_name": "Luis Pedraza", 
                    "phone": "305-805-0921"
                }, 
                "facility": {
                    "address": {
                        "city": "Miami Springs", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33166"
                    }, 
                    "name": "Galiz Research"
                }, 
                "investigator": {
                    "last_name": "Jose Gamez, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "DMarsh@CompassResearch.com", 
                    "last_name": "Dan Marsh", 
                    "phone": "407-210-1310"
                }, 
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32806"
                    }, 
                    "name": "Compass Research"
                }, 
                "investigator": {
                    "last_name": "Ira Goodman, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Lindsay_M_Pluff@rush.edu", 
                    "last_name": "Lindsay Pluff", 
                    "phone": "312-563-4111"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Rush University Medical Center"
                }, 
                "investigator": {
                    "last_name": "Raj Shah, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "blokaitis@siumed.edu", 
                    "last_name": "Barbara C Lokaitis, BA", 
                    "phone": "217-545-9737"
                }, 
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62702"
                    }, 
                    "name": "Southern Illinois University School of Medicine"
                }, 
                "investigator": {
                    "last_name": "Thomas A Ala, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "joannabachowska@yahoo.com", 
                    "last_name": "Joanna Bachowska", 
                    "phone": "702-521-8950"
                }, 
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89113"
                    }, 
                    "name": "Las Vegas Radiology"
                }, 
                "investigator": {
                    "last_name": "Bobby Mocherla, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "csollars@montefiore.org", 
                    "last_name": "Mark Sollars", 
                    "phone": "718-405-8363"
                }, 
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10461"
                    }, 
                    "name": "Albert Einstein College of Medicine"
                }, 
                "investigator": {
                    "last_name": "Jessica Zwerling, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "rfries@wakehealth.edu", 
                    "last_name": "Rose Fries", 
                    "phone": "336-713-8462"
                }, 
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27157"
                    }, 
                    "name": "Wake Forest Baptist Health-Gerontology"
                }, 
                "investigator": {
                    "last_name": "Kaycee Sink, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology", 
        "overall_contact": {
            "email": "jshuping@navidea.com", 
            "last_name": "Joanna Shuping, BS", 
            "phone": "+1-614-822-2388"
        }, 
        "overall_contact_backup": {
            "email": "chartings@navidea.com", 
            "last_name": "Carley Hartings, MPH", 
            "phone": "+1-614.973.7558"
        }, 
        "overall_official": {
            "affiliation": "Navidea Biopharmaceuticals", 
            "last_name": "Cornelia Reininger, MD PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Incidence of [18F]NAV4694 Brain PET scan positivity compared to histopathology", 
            "safety_issue": "No", 
            "time_frame": "6 Months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01886820"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Quantification of [18F]NAV4694 brain PET Scan positivity compared to histopathology", 
                "safety_issue": "No", 
                "time_frame": "6 Months"
            }, 
            {
                "measure": "Incidence of [18F]NAV4694 PET Scan positivity in 6 pre-specified brain regions compared to histopathology", 
                "safety_issue": "No", 
                "time_frame": "6 Months"
            }, 
            {
                "measure": "Quantification of [18F]NAV4694 PET Scan positivity in 6 pre-specified brain regions compared to histopathology", 
                "safety_issue": "No", 
                "time_frame": "6 Months"
            }, 
            {
                "measure": "Incidence of adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Navidea Biopharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Navidea Biopharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}